Stay updated on Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a new version of the page was published. This update reflects version control activity rather than a change to the study content.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedThe page’s technical release/version label was updated from **v3.5.2** to **v3.5.3**, reflecting a platform update rather than any change to the study information.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No visible changes to study content.SummaryDifference0.1%

- Check110 days agoChange DetectedA new Revision: v3.4.2 tag was added and the earlier Revision: v3.4.1 funding-status notice was removed, which are maintenance updates that do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.